Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Boston Scientific Corporation (BSX) M&A Call Transcript
12:05pm, Thursday, 15'th Jan 2026
Boston Scientific Corporation (BSX) M&A Call Transcript
Boston Scientific to acquire Penumbra in $14.5B deal
12:05pm, Thursday, 15'th Jan 2026
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) announced a definitive agreement to acquire medical device company Penumbra (NYSE:PEN) in a cash and stock transaction valuing Penumbra at $374 per share,
BALA CYNWYD, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j
Active Energy shares move to OTCID market in US
10:40am, Thursday, 15'th Jan 2026
Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) said its shares have moved from the OTCQB Venture Market to the OTC Integrated Disclosure Market in the...
Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal
10:17am, Thursday, 15'th Jan 2026
Boston Scientific Corp. (BSX) said it has agreed to acquire Penumbra Inc. (PEN) in a transaction valued at more than $14 billion, marking a significant step in
BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies
09:25am, Thursday, 15'th Jan 2026
Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.
Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach
09:11am, Thursday, 15'th Jan 2026
Boston Scientific on Thursday announced plans to acquire Penumbra, a US-based thrombectomy specialist, in a cash-and-stock deal valued at about $14.5 billion, marking one of the largest transactions i
Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.
08:45am, Thursday, 15'th Jan 2026
The cash-and-stock acquisition values Penumbra at $374 a share.
Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments
08:11am, Thursday, 15'th Jan 2026
Penumbra's stock was up about 14% after the deal was announced Thursday morning.
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
07:19am, Thursday, 15'th Jan 2026
Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Boston Scientific to buy Penumbra in deal valued at $14.5 billion
07:07am, Thursday, 15'th Jan 2026
Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion.
Boston Scientific announces agreement to acquire Penumbra, Inc.
07:00am, Thursday, 15'th Jan 2026
Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical thrombectomy and neurovascular,
Super Micro Computer (NASDAQ:SMCI) Shares Unloaded Sen. John Boozman
02:08am, Thursday, 15'th Jan 2026
Senator John Boozman (R-Arkansas) recently sold shares of Super Micro Computer, Inc. (NASDAQ: SMCI). In a filing disclosed on January 13th, the Senator disclosed that they had sold between $1,001 and
Sen. John Boozman Unloads Shares of iShares Silver Trust (NYSEARCA:SLV)
02:08am, Thursday, 15'th Jan 2026
Senator John Boozman (R-Arkansas) recently sold shares of iShares Silver Trust (NYSEARCA:SLV). In a filing disclosed on January 13th, the Senator disclosed that they had sold between $1,001 and $15,00
SPDR S&P Regional Banking ETF (NYSEARCA:KRE) Stock Unloaded Sen. John Boozman
02:08am, Thursday, 15'th Jan 2026
Senator John Boozman (R-Arkansas) recently sold shares of SPDR S&P Regional Banking ETF (NYSEARCA:KRE). In a filing disclosed on January 13th, the Senator disclosed that they had sold between $1,001 a
